Advanced search
Publication Cover
Journal of Musculoskeletal Pain Volume 9, 2001 - Issue 1
Journal homepage
11
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Open Label Assessment of Botulinum Toxin A for Pain Treatment in a Private Outpatient Setting

Anthony H. Wheeler Charlotte Spine Center, Charlotte, NC
&
Paula Goolkasian University of North Carolina at Charlotte, Department of Psychology, 9201 University City Boulevard, Charlotte, NC, 28233-0001
Pages 67-82 | Received 13 Apr 2000, Accepted 26 Sep 2000, Published online: 16 Jan 2010

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

I. Jon Russell. (2001) Is It My Fibromyalogia, Doctor?. Journal of Musculoskeletal Pain 9:1, pages 1-5.
Read now

Articles from other publishers (17)

Jagannatha Sahoo, Debasish Jena, Amrutha Viswanath & Apurba Barman. (2021) Injection Botulinum Toxin A in Treatment of Resistant Chronic Low Back Pain: A Prospective Open-Label Study. Cureus.
Crossref
Diana Carolina Nájera Losada, John Carlos Pérez Moreno & Agustín Mendiola de la Osa. (2021) Toxina botulínica en el tratamiento del síndrome de dolor miofascial. Revista de la Sociedad Española del Dolor 28.
Crossref
Alberto Jaime Kalach-Mussali & Daniel Mondlak Algazi. 2018. Botulinum Toxin. Botulinum Toxin.
Anthony Wheeler & Howard S. Smith. (2013) Botulinum toxins: Mechanisms of action, antinociception and clinical applications. Toxicology 306, pages 124-146.
Crossref
Tony Zhang, Aleem Adatia, Wasifa Zarin, Misha Moitri, Abi Vijenthira, Rong Chu, Lehana Thabane & Walter Kean. (2010) The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology 19:1, pages 21-34.
Crossref
Leonidas Manolopoulos, Petros V. Vlastarakos, Lucas Georgiou, Ioannis Giotakis, Anthony Loizos & Thomas P. Nikolopoulos. (2008) Myofascial pain syndromes in the maxillofacial area: a common but underdiagnosed cause of head and neck pain. International Journal of Oral and Maxillofacial Surgery 37:11, pages 975-984.
Crossref
Kok‐Yuen Ho & Kian‐Hian Tan. (2012) Botulinum toxin A for myofascial trigger point injection: A qualitative systematic review. European Journal of Pain 11:5, pages 519-527.
Crossref
Guy Monnier, Laurent Tatu & Fabrice Michel. (2006) Les indications de la toxine botulinique en rhumatologie. Revue du Rhumatisme 73:12, pages 1331-1337.
Crossref
Guy Monnier, Laurent Tatu & Fabrice Michel. (2006) New indications for botulinum toxin in rheumatology. Joint Bone Spine 73:6, pages 667-671.
Crossref
John P. Ney, Marc Difazio, Afsoun Sichani, William Monacci, Leslie Foster & Bahman Jabbari. (2006) Treatment of Chronic Low Back Pain With Successive Injections of Botulinum Toxin A Over 6 Months. The Clinical Journal of Pain 22:4, pages 363-369.
Crossref
A. Kamanli, A. Kaya, O. Ardicoglu, S. Ozgocmen, F. Ozkurt Zengin & Y. Bayık. (2004) Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatology International 25:8, pages 604-611.
Crossref
&NA;. (2005) Relieve pain and restore normal function and strength to muscles in patients with myofascial pain disorders. Drugs & Therapy Perspectives 21:1, pages 11-14.
Crossref
Anthony H Wheeler. (2004) Myofascial Pain Disorders. Drugs 64:1, pages 45-62.
Crossref
Cindy B. Ivanhoe & Eric T. Hartman. (2004) Clinical Caveats on Medical Assessment and Treatment of Pain After TBI. Journal of Head Trauma Rehabilitation 19:1, pages 29-39.
Crossref
Amy M. Lang. (2003) A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: A retrospective, open-label chart review. Clinical Therapeutics 25:8, pages 2268-2278.
Crossref
Geoffrey Sheean. (2002) Botulinum toxin for the treatment of musculoskeletal pain and spasm. Current Pain and Headache Reports 6:6, pages 460-469.
Crossref
Anthony H. Wheeler, Paula Goolkasian & Stephanie S. Gretz. (2001) Botulinum toxin A for the treatment of chronic neck pain. Pain 94:3, pages 255-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.